Pacific Biosciences of California announces pricing of public offering of common stock
Pacific Biosciences of California announced it has priced its underwritten public offering of 12,500,000 shares of its common stock at a price to the public of $2.40 per share. Pacific Biosciences granted underwriters a 30-day option to purchase up to an additional 1,875,000 shares. February 13, 2018